A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects

Condition:   Advanced Solid Tumor Interventions:   Drug: Apatinib Mesylate;   Drug: Repaglinide;   Drug: Bupropion Sponsor:   Jiangsu HengRui Medicine Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials